Price Chart

Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.75% 0.03% 19.55M 489.03
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.78% 46.00% -3.348M

Basic Info

Investment Strategy
The Fund seeks long-term growth of capital. The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in equity investments in U.S. and non-US health care companies. The Adviser generally defines a health care company as a company in the health care sector.
General
Security Type Exchange-Traded Fund
Equity Style Multi Cap Growth
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Health/Biotechnology Funds
Fund Owner Firm Name Goldman Sachs
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
--
--
--
-17.12%
4.60%
-1.66%
10.74%
4.93%
27.67%
15.90%
21.82%
-18.14%
23.79%
18.67%
21.09%
12.13%
--
--
--
--
--
--
--
15.27%
--
--
--
--
24.84%
0.57%
27.06%
6.02%
--
--
--
--
--
2.29%
9.69%
18.64%
20.80%
15.56%
23.41%
-4.46%
2.15%
2.99%
13.16%
10.55%
As of September 18, 2026.

Asset Allocation

As of August 31, 2026.
Type % Net
Cash 0.98%
Stock 98.41%
Bond 0.61%
Convertible 0.00%
Preferred 0.00%
Other 0.00%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks long-term growth of capital. The Fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in equity investments in U.S. and non-US health care companies. The Adviser generally defines a health care company as a company in the health care sector.
General
Security Type Exchange-Traded Fund
Equity Style Multi Cap Growth
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Health/Biotechnology Funds
Fund Owner Firm Name Goldman Sachs
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders